Home › Bladder Cancer › Florida › Gainesville
Bladder Cancer clinical trials in Gainesville, FL
4 studies for Bladder Cancer are looking for participants at sites in and around Gainesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RecruitingPhase 3
- UF Health Cancer Institute - Gainesville, Gainesville
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RecruitingPhase 2
- UF Health Cancer Institute - Gainesville, Gainesville
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RecruitingPhase 2
- University of Florida, Gainesville
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
RecruitingPhase 2
- University of Florida, Gainesville
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY35 studies
- Nashville, TN31 studies
- Houston, TX31 studies
- Dallas, TX27 studies
- Boston, MA26 studies
- Washington, DC26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Philadelphia, PA21 studies
- Seattle, WA21 studies
- Edison, NJ21 studies
Other studies in Gainesville
- Heart Failure13 studies
- Breast Cancer12 studies
- Type 1 Diabetes12 studies
- Parkinson's Disease12 studies
- Non-Small Cell Lung Cancer10 studies
- Colorectal Cancer9 studies
- Lung Cancer9 studies
- Cancer (all types)9 studies
- Cardiovascular Disease9 studies
- Prostate Cancer8 studies
- Mild Cognitive Impairment8 studies
- Acute Myeloid Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.